Tumor infiltrating lymphocytes (TILs) improve prognosis in patients with triple negative breast cancer (TNBC)

Upon analysis of archived primary tumors of 482 patients with triple negative breast cancer (TNBC) enrolled in two randomized Phase III adjuvant chemotherapy trials, we have found that tumor infiltrating lymphocytes (TILs), as assessed and quantified by hematoxylin and eosin (H&E) staining are a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Oncoimmunology
Autores principales: Adams, Sylvia, Goldstein, Lori J, Sparano, Joseph A, Demaria, Sandra, Badve, Sunil S
Formato: Artigo
Lenguaje:Inglês
Publicado: Taylor & Francis 2015
Materias:
Author's View
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4570112/
https://ncbi.nlm.nih.gov/pubmed/26405612
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/2162402X.2014.985930
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares